期刊文献+

9例甲状腺髓样癌的临床诊断与治疗 被引量:1

Clinical Diagnosis and Treatment of 9 Cases of Medullary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺髓样癌(medullary thyroid carcinoma,MTC)的临床诊断与治疗。方法回顾分析2005年1月至2011年1月南京医科大学附属南京第一医院收治的9例MTC的临床资料。结果 9例患者都以颈部肿块就诊,手术以甲状腺叶全切除+中央区淋巴结清扫术为主,总的淋巴结转移率为44.44%。术后均口服左甲状腺素片,随访5年以上3例,术后复发2例。结论甲状腺髓样癌术前确诊困难,血清降钙素可作为术前诊断最重要的指标。首次手术的彻底性是治愈甲状腺髓样癌的必要手段。术后监测血清降钙素有助于发现甲状腺髓样癌残留和复发。 Objective To discuss the clinical diagnosis and treatment of medullary carcinoma of thyroid.Methods The clinical data of 9 cases of MTC from Nanjing First Hospital affiliated to Nanjing Medical University was retrospectively analyzed.Results The clinical manifestations in most patients with MTC were the cervical mass.Total thyroidectomy and cervical lymph node dissection were performed in all patients.The lymph node metastasis rate was 44.44%.The patient take L-thyroxine after the surgery.In 3 cases who were followed up for 5 years,2 cases of recurrent.Conclusion MTC was difficult to be diagnosed preoperatively.Serum calcitonin preoperative diagnosis can be used as the most important indexAn aggressive surgical approach at the initial operation is essential to achieve a curative effect in patient with MTC.Measuring plasma calcitonin postoperatively helps to detect residuled MTC or recurrent MTC.
作者 杨征
出处 《中国医药指南》 2012年第26期25-26,共2页 Guide of China Medicine
关键词 甲状腺髓样癌 降钙素 手术治疗 Medullary thyroid carcinoma Calcitonin Surgical therapy
  • 相关文献

参考文献6

二级参考文献18

  • 1Forrst CH, Frost FA, de-Boer WB. Medullary carcinoma of the thyroid : accuracy of the diagnosis of fine-needle aspimtion cytology.Cancer, 1998,84 : 295-302.
  • 2Takano T. Myauchi A, Matsuzuka F, et al. Preoperative diagnosis of medullaxy thyroid carcinoma by RF-PCR using RNA extracted form leftover cell within a needle used for fine needle aspiration biopsy . J Clin Endocrinol Metab, 1999,84:951-955.
  • 3Brunt LM, Wells SA Jr. Advances in the diagnosis and treatment of medullary thyroid carcinoma [J].Surg Clin North Am,1987,67(2):263-279.
  • 4李树玲.头颈肿瘤学[M].天津:天津科学技术出版社,1995.752.
  • 5Belli S, Storani ME, Dourisboure RJ, et al. Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers[J]. Medicina (B Aires), 2003, 63(1):41-45. Spanish.
  • 6Cohen R,Campos JM,Salaun C,et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC)[J]. J Clin Endocrinol Metab, 2000, 85(2):919-922.
  • 7Schilling T, Burck J, Sinn HP, et al. Prognostic value of codon 918 (ATG→ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma[J]. Int J Cancer,2001,95(1):62-66.
  • 8Dralle H, Gimm O, Simon D, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience[J]. World J Surg, 1998, 22(7):744-750; discussion 750-751.
  • 9van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma[J]. Ann Surg, 1990, 212(4):395-400; discussion 400-401.
  • 10Jensen MH, Davis RK, Derrick L. Thyroid cancer: a computer-assisted review of 5287 cases[J]. Otolaryngol Head Neck Surg, 1990, 102(1):51-65.

共引文献12

同被引文献11

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部